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ABSTRACT
Background: To increase recognition of airflow
obstruction in primary care, we compared two models of
spirometry delivery in a target group at risk of chronic
obstructive pulmonary disease (COPD).
Methods: A 6 month qualitative/quantitative cluster
randomised study in eight practices compared opportu-
nistic spirometry by ‘‘visiting trained nurses’’ (TN) with
optimised ‘‘usual care’’ (UC) from general practitioners
(GPs) for smokers and ex-smokers, aged over 35 years.
Outcomes were: spirometry uptake and quality, new
diagnoses of COPD and GPs’ experiences of spirometry.
Results: In the eligible target population, 531/904 (59%)
patients underwent spirometry in the TN model and 87/
1130 (8%) patients in the UC model (p,0.0001). ATS
spirometry standards for acceptability and reproducibility
were met by 76% and 44% of tests in the TN and UC
models, respectively (p,0.0001). 125 (24%) patients
tested with the TN model and 38 (44%) with the UC
model reported a pre-existing respiratory diagnosis
(p,0.0001). Three months after spirometry, when the
ratio of forced expiratory volume in 1 s/forced vital
capacity (FEV1/FVC) was ,0.7 and no prior COPD
diagnosis was reported, nine (8%) participants had a new
doctor recorded COPD diagnosis in practices with the TN
model and two (8%) participants in practices with the UC
model. Mislabelling of participants with a diagnosis of
COPD when FEV1/FVC was >0.7 was present in both
models prior to and after spirometry. GPs valued high
quality spirometry and increased testing of patients at risk
of COPD in the TN model. They identified limitations,
including the need for better systematic follow-up of
abnormal spirometry and support with interpretation,
which may explain persisting underdiagnosis of COPD in
practice records.
Conclusions: Although opportunistic testing by visiting
trained nurses substantially increased and improved
spirometry performance compared with usual care,
translating increased detection of airflow obstruction into
diagnosis of COPD requires further development of the
model.
Trial registration number: Australian Clinical Trials
Registry: registration No 12605000019606.
A high proportion of chronic obstructive pulmon-
ary disease (COPD) in the community remains
undiagnosed.1 2 Previously unrecognised airflow
obstruction was found in 19% of current smokers
over 35 years of age in general practice3 and
although spirometry is essential for the diagnosis
of COPD,4 5 performing spirometry in primary care
is not without difficulties. These include lack of
access to reliable equipment, lack of training,
patient reluctance to travel and financial disin-
centives.6–8 There has been little operational
research on how to overcome such practical
difficulties. The aim of this study was to compare
the effects of two practice based models of
spirometry delivery, opportunistic spirometry by
visiting trained nurses and ‘‘usual care’’ in practices
provided with equipment, training and payment,
on spirometry uptake and application in patients
at risk of COPD and translation into new
diagnoses of COPD recorded by general practi-
tioners (GPs).
METHODS
Participants and study design
Practices were recruited through a newsletter
distributed to all practices in Southern Tasmania
(74 urban/suburban and 20 rural). Six urban and
two rural general practices responded and were
included and randomised. The study protocol was
approved by the Southern Health and Medical
Human Research Ethics Committee. Signed
informed consent was obtained from GPs in
participating practices and from patients at recruit-
ment, which occurred between November 2004
and June 2005.
Spirometry delivery models
Using a random numbers table, practices were
randomised to models for delivery of spirometry to
patients in the target group at risk of COPD
defined by: age over 35 years and ever smoked
regularly. In the trained nurse model (TN), nurses
trained in spirometry testing visited each practice
for two 3 h sessions per week to perform oppor-
tunistic testing. Practice staff invited any patient in
the target group who attended during a spirometry
session to undergo lung function testing.
Spirometry was also advertised by posters or
performed at the request of GPs. Printed spirom-
eter output (without classification or interpreta-
tion) was faxed to GPs within 48 h.
In the usual care model (UC) model, a spirom-
eter was provided to the practice and education
and spirometry training given. After training,
spirometry was performed by a GP or practice
nurse/assistant according to the usual practice
protocol. Practice publicity was discretionary (eg,
computer generated reminders or posters).
Practices retained spirometry traces for GP inter-
pretation and received reimbursement for patients
tested in the target group (AUS$10, proportionate
to an existing Australian Medicare schedule fee for
spirometry with reversibility testing).
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Spirometry training
In practices receiving either intervention, GPs and other
nominated staff were trained during a 2 h workshop (see
appendix 1) by a physiologist and respiratory specialist
physician in performance of spirometry (theory and practice),
interpretation and criteria for diagnosing COPD according to
Global Initiative for Chronic Obstructive Lung Disease (GOLD)4
and Australian5 guidelines (forced expiratory volume in 1 s/
forced vital capacity (FEV1/FVC) ,0.7).
Outcome data collection
Spirometry uptake and acceptability
Demographic data were collected for all patients offered
spirometry. Additionally, reasons for accepting or refusing
spirometry were recorded for patients offered an opportunistic
test. Participants undergoing spirometry completed question-
naires recording smoking history, assessment of functional
breathlessness using the Medical Research Council (MRC)
dyspnoea scale9 and self-reported use of respiratory medications
and diagnoses.
Spirometry
Spirometry was performed in all practices using an ultrasonic
electronic spirometer (EasyOne, NDD Medizintechnik AG,
Technoparkstrasse, Switzerland). This spirometer has the
advantage of stability,10 inbuilt quality assurance features,11
classifies tests using grades (A–D, F) for reliability (see appendix
2) and provides prompts to optimise performance. Investigators
performed regular calibration checks. A spirometry test con-
sisted of three expiratory manoeuvres (emphasising full
inspiration and complete exhalation) meeting American
Thoracic Society (ATS) acceptability and repeatability criteria,
performed without bronchodilator reversibility testing.11 The
time to complete testing was recorded in the TN model.
Predicted values were calculated from Knudson and colleagues.12
Reports provided to GPs included the parameters FEV1, FVC,
FEV1/FVC ratio, forced expiratory flow (FEF)25–75%,, peak
expiratory flow and forced expiratory time for three acceptable
manoeuvres with corresponding flow–volume and volume–time
curves.
Quality assurance
Spirometry was assessed by investigators against contemporary
ATS criteria11 for acceptability and repeatability (see appendix
2). The proportions of acceptable spirometry that showed a
difference between the best two FEV1 and best two FVC
(200 ml (grade A or B) were compared between models. The
utility of spirometry for interpretation by GPs was evaluated by
assessing the proportion of spirometry of poor quality grades
(D, two acceptable but not repeatable tests; F, only one
acceptable test or no acceptable test achieved).
Impact of spirometry on diagnosis of COPD
A definition of the presence of airflow obstruction (AO) based
on the principal criterion (FEV1/FVC ,0.7) specified in (GOLD)
guidelines4 was used for investigator assessment of a doctor
diagnosis of COPD following spirometry.13 When spirometry
met any of the following criteria, practice records of patients
belonging to the target group were examined by investigators
3 months later: FEV1/FVC ,85% predicted, FEV1 ,80%
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Figure 1 Study flow chart. FTE, full time
equivalent; GP, general practitioner; PN,
practice nurse. Target group: age
>35 years, smoker or ex-smoker.
Table 1 Characteristics of patients belonging to the target group (age
>35 years, ever smoker) undergoing spirometry in practices by
spirometry delivery model
Visiting trained
nurse spirometry
(n= 531)
Usual care
spirometry
(n= 87) p Value
Males (%) 258 (48.6) 41 (47.1) 0.78
Current smokers (%) 204 (38.4) 32 (37.6) 0.69
Age (y)* 56.0 (21.0) 57.4 (21.0) 0.94
Smoking history (pack years)* 26.3 (27.4) 35.6 (31.4) 0.15
MRC functional dyspnoea >3 (%) 127 (23.9) 35 (40.2) ,0.0001
Self-report respiratory diagnosis{ (%) 125 (23.5) 38 (43.7) ,0.0001
Self-report diagnosis of COPD (%) 33 (6.2) 11 (12.8) 0.04
FEV1 % predicted{ 95.0 (26.0) 86.5 (34.0) 0.07
Data are presented as *median and IQR.
{Asthma, chronic obstructive pulmonary disease, chronic bronchitis or other
participant specified diagnosis.
FEV1, forced expiratory volume in 1 s; MRC, Medical Research Council.
Chronic obstructive pulmonary disease
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predicted, FVC ,80% predicted or FEF25–75% ,55% predicted.
Data were extracted on further investigations by GPs, including
post-bronchodilator spirometry, and doctor recorded diagnoses
of respiratory disease before and after spirometry.
Qualitative assessment of spirometry delivery models
At the conclusion of the study, focus group discussions were
conducted with GPs in each practice. A trained facilitator used
both general and specific questions relevant to each spirometry
model with case scenarios to generate discussion.14
Statistical analysis
Two trained nurses were expected to recruit a maximum of 30
patients per week for opportunistic spirometry. No data on the
rate of spirometry refusal in the target group were available.
Assuming a 25% refusal rate, we anticipated testing a maximum
of 1170 participants in four TN practices. Based on a previous
study,7 the expected rate of spirometry was 2.3 tests per week,
240 tests in UC practices. Planned comparisons were the
number of tests performed in 6 months and proportions of
the eligible target group tested in practices. The eligible
population in the TN model consisted of patients in the target
group who attended for any reason during spirometry sessions
over 6 months, calculated as the number invited plus those who
missed an invitation to participate. The eligible population in
the UC model consisted of all patients in the target group who
consulted a GP at least once during the study. This was
calculated from consultation numbers during 6 months minus:
numbers of lifelong non-smokers and under 35 year of age,
allowing for the proportion of patients making repeat atten-
dances estimated from attendance data extracted from practice
records. Quantitative data analyses were performed using SPSS
V.14.0 and STATA V.10. Variables are presented as means (SD)
or median (interquartile range (IQR)) if non-normally distrib-
uted. Clustering was taken into account in regression analyses
with random intercepts using multi-level mixed effects linear
models or generalised linear latent and mixed models.
Comparison of proportions tested in practices was performed
using a t test weighted by the number of eligible patients.15
Statistical significance was set at the 5% level.
Qualitative data were analysed using NVivo (V.2, Qualitative
Solutions and Research International, Melbourne, Victoria,
Australia). Focus group discussions were audiotaped and
transcribed verbatim. An iterative process of inductive category
development was used for content analysis.14 Two researchers
(JW, JG or EH) listened to all tapes to identify the initial themes.
JW analysed transcripts line-by-line, coded relevant themes and
categories, and recorded thematic development using memos.
Emergent themes were verified by EH and discussed among all
authors. Themes and sub-themes were compared by spirometry
delivery models. Examples of quotes were used to illustrate
themes.
RESULTS
Spirometry uptake, application and feasibility
Opportunistic spirometry was performed on 531 participants in
the target group of patients in the TN model while 87
participants in the target group were tested by GPs or practice
nurses in the UC model over a period of 6 months. There was a
significant difference between proportions of the estimated
eligible target group population that underwent spirometry in
practices in the TN model and in practices with the UC model
(p,0.0001), overall 58.7 versus 7.7% (fig 1).
Patients tested in the target group in both delivery models
had similar profiles for age, gender, current smoker status and
smoking pack-year history (table 1). In the TN model, a lower
proportion of patients tested opportunistically reported a pre-
existing respiratory diagnosis and a lower proportion had
functional dyspnoea of MRC grade 3 or 4 compared with those
tested in the UC model (table 1). Airflow obstruction (FEV1/
FVC,0.7) was present in 127 (23.9%) patients tested in the TN
model and in 29 (33.3%) patients tested in the UC spirometry
delivery model (p=0.06). When participants reported no prior
diagnosis of COPD, the severity of airflow obstruction classified
using GOLD4 in the TN model compared with the UC model
was: mild in 48 (44.9%) versus seven (27.4%), moderate in 48
(44.9%) versus 12 (48.0%), severe in 10 (9.3%) versus three
(12.0%) and very severe in one (1%) versus three (12.0%)
(p=0.03).
An invitation to undergo spirometry testing in the TN model
was offered to 783 patients and refused by 252 patients (32%)
(fig 1). Patient specified reasons for refusing were generally
either ‘‘feeling too unwell’’ or ‘‘lack of time on this visit to the
GP’’ (table 2). Only a minority were ‘‘not interested in knowing
their lung function’’ or refused because they ‘‘thought their
lungs were OK’’. Among patients who accepted, the most
frequent reason was ‘‘I’d like to know my lung function’’.
Median time taken for opportunistic spirometry testing in the
TN model was 5 min (IQR 2) and the median number of
attempts required to complete acceptable spirometry was 4
(IQR 2).
Spirometry quality
Spirometry grading was A or B in 421/551 (76.4%) tests in the
TN model compared with 66/151 (43.7%) tests performed in the
UC model by GPs and practice nurses (p,0.0001). Grading was
C for 78 (14.2%) and 29 (19.2%) and D or F in 52 (9.5%) and 56
(37.0%) in 551 TN tests and 151 UC tests, respectively
(p,0.0001).
Impact of spirometry on diagnosis of COPD
Examination of practice records
A total of 277 (52%) tests conducted in the TN model and 39
(45%) tests conducted in the UC model did not meet the pre-
specified spirometric criteria for proceeding to practice record
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Table 2 Patients’ reasons* for accepting or declining spirometry in practices with the trained nurse model of
spirometry delivery
Spirometry performed (n=531) (%) Refused spirometry (n= 252) (%)
Like to know lung function 341 (65.1) Not interested in knowing 64 (25.5)
Check up 315 (60.6) Think lungs are OK 52 (20.7)
Worried about my lungs 123 (23.4) Result might worry me 17 (6.8)
Saw a poster 95 (18.7) Do not like having tests 13 (5.2)
Other—patient specified 68 (13.0) Other—patient specified 176 (70.7)
*Multiple responses permitted.
Chronic obstructive pulmonary disease
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data extraction. In patients whose spirometry met the criteria,
data extraction was successfully completed for 266 (89%)
patients in practices with the TN model and in 40 (83%)
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Figure 2 Impact of spirometry on the
diagnosis of chronic obstructive
pulmonary disease (COPD) in practices
receiving the visiting trained nurse (TN) or
usual care (UC) model of spirometry
delivery. AO, spirometry demonstrated
airflow obstruction forced expiratory
volume in 1 s/forced vital capacity (FEV1/
FVC),0.7. Target group: age>35 years,
smoker or ex-smoker.
Table 3 Summary of themes on spirometry from focus group discussions with general practitioners in
practices receiving the visiting trained nurse (TN) model or usual care (UC) model of spirometry delivery
Spirometry theme TN UC Typical examples of statements by a GP
High quality essential Yes Yes ‘‘It seems quite critical, that the person doing the actual testing is
trained, and is aware of patients’ technique’’ TN model
GPs lack time to perform good quality spirometry No Yes ‘‘You’d have to use it all the time to get really efficient’’ UC model
Initiation by GPs not required Yes No ‘‘I probably wouldn’t be requesting spirometry, unless I already
knew there was a problem’’ TN model
Nurse performed spirometry is less threatening for
patients
Yes Yes Nurses are ‘‘not too authoritarian’’ and are ‘‘very non-threatening’’
TN model
Systematic follow-up not achieved Yes No ‘‘It is fitted in among whatever is of primary concern to them, and
so tends to go to the bottom of the heap’’ TN model
Lack of ownership of test result Yes No ‘‘If I order a test I have some obligation to follow-up the results and
discuss it with the patient’’ TN model
Use in differential diagnosis Yes Yes ‘‘I am looking for a reason why they are short of breath’’ UC model
Emphasis on clinical basis for diagnosis of
respiratory disease
Yes Yes ‘‘You can support what you already know, she is developing a
respiratory problem with her smoking’’ TN model
Usefulness of recording a diagnosis of COPD Yes Yes ‘‘If you give them a label or not, I think it depends on what
impression you give of how serious it actually seems to be, rather
than just a label.’’ TN model
Classifying the severity of COPD Yes Yes ‘‘Well it helps you in making a diagnosis and helps you to quantify
the degree of damage’’ TN model
Objective measurement useful in future Yes No ‘‘Same as with hypertension, you have got a baseline of respiratory
function’’ TN model
Identifying and recording smoking status Yes Yes ‘‘I have identified a few patients who I didn’t know were smokers. I
always thought I could smell them’’ UC model
‘‘I have been unaware they are smokers, or even ex-smokers’’ TN
model
Discussing smoking cessation Yes Yes ‘‘It is an entry into talking about how to give up’’ TN model
Personalise quit advice Yes Yes ‘‘You could say that if she stopped smoking there is a good chance
she won’t get any worse’’ UC model
Cost a disincentive without appropriate funding Yes Yes ‘‘Unless you are doing full lung function, you can’t claim anything’’
UC model
Chronic obstructive pulmonary disease
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patients in practices with the UC model. Records for 37 patients
were unavailable to investigators.
In practices with the TN spirometry model, 190 (84%)
patients had consulted a GP by 3 months after spirometry and
in these patients there were 11 new doctor recorded diagnoses of
COPD, 2.2% of participants without prior self-reported COPD
(fig 2). When spirometry demonstrated airflow obstruction
(FEV1/FVC ,0.7), there were nine new doctor recorded
diagnoses of COPD, an 8.3% increase by 3 months following
spirometry. Two patients with an FEV1/FVC ratio >0.7 had a
new doctor recorded COPD diagnosis. Among participants with
a prior self-reported diagnosis of COPD, 19 (60%) demonstrated
airflow obstruction. In practices with the UC spirometry model,
two (8%) participants with airflow obstruction received a new
doctor recorded diagnosis of COPD (fig 2). Among those with a
prior self-reported COPD diagnosis, four (36%) demonstrated
airflow obstruction.
Cost of spirometry in TN model
The cost of opportunistic spirometry in the TN model over
6 months was AUS$42 704 ($804 for spirometry training
courses, $33 800 for nurse costs, $6500 for spirometers, $1600
for spirettes). The cost per new case of doctor recorded
obstructive airways disease where spirometry in the target
group showed airflow obstruction (FEV1/FVC ,0.7) would be
AUS$555 if all cases received a diagnosis. However, for the 12
new doctor recorded diagnoses of COPD or asthma, the cost
was AUS$3559 per case (J2246).
GP experience
Fifteen GPs (52%) from practices with the TNmodel and 13 GPs
(68%) from practices with the UC spirometry model partici-
pated in six in-depth focus groups. Of the major themes that
emerged (table 3), some were important for GPs from practices
with either spirometry model, such as the need for appropriate
spirometry reimbursement and the necessity of achieving high
quality results. Only in practices with the UC model did GPs
emphasise their own difficulties in performing spirometry and
the paramount importance of having a practice nurse to
perform spirometry testing. GPs in practices with the TN
model thought GP initiated spirometry would be unlikely in the
absence of a prior diagnosis and felt that opportunistic
spirometry had major advantages for convenience and accept-
ability to patients. This was particularly relevant for smokers
who might be reluctant to raise concerns about respiratory
symptoms with GPs, because they felt guilty about self-induced
lung damage. Organised follow-up, specifically focussed on
spirometry, was thought essential in both models of spirometry,
but a recall system after opportunistic testing would increase an
already heavy GP workload and increase costs for patients in
Australian primary care.
All GPs claimed to use spirometry to diagnose COPD but
rarely in isolation, often placing greater emphasis on other
clinical patient information. They questioned the value of the
label, both in terms of patient understanding and promoting
change in patient behaviour. A label was felt by some GPs to
lack intrinsic value in the absence of a cure. When considering
the scenario of a patient with spirometry typical of moderate
COPD, various terms used as labels included ‘‘reduced lung
function’’, ‘‘obstructive’’ and ‘‘respiratory problem’’, and COPD
was rarely specifically named. GPs varied in their knowledge of
spirometric indices, but most expressed uncertainty and agreed
they needed assistance with interpretation. Options suggested
were: developing expertise within a practice, computerised
support or outside expert interpretation. Flow–volume curves
were valued by GPs themselves in assessing the presence of
obstruction and in demonstrating this to patients. Only GPs in
practices with the TN model valued spirometry for monitoring
lung function objectively and compared this positively to
routine management of other chronic diseases such as diabetes
and hypertension.
The most likely consequences of spirometry elicited from GPs
in both spirometry models were being prompted to identify and
record patients’ smoking status and initiate discussion on
cessation. Spirometry, even when normal, was used to
personalise and reinforce advice on quitting.
DISCUSSION
This study was unique in using qualitative assessment to
explore and validate quantitative findings16 17 of the impact of
two models of delivery of spirometry in general practice.18 We
found that opportunistic trained nurse performed spirometry
led to a substantially higher proportion of the population at risk
of developing COPD having spirometry performed compared
with usual care by GPs equipped and trained in spirometry.
Spirometry performed in both models resulted in an increase in
GP diagnosis of COPD. However, in practices with the visiting
TN model, substantial underdiagnosis remained after a period
that allowed for follow-up and further investigations in patients
with spirometric evidence of airflow obstruction.
Direct invitations for spirometry by a nurse were highly
acceptable to patients and GPs, although we had a higher non-
participation rate compared with other similar studies,3 19
mainly caused by time constraints and illness in this opportu-
nistic testing model within the GP clinic. However, the study
design aimed to reflect busy ‘‘real world’’ general practice, both
without pre-selection or exclusions in the target group and in
utilisation and interpretation of spirometry by GPs.
The high proportion of visiting nurse performed spirometry
satisfying ATS standards for acceptability and repeatability11
was similar to that reported in studies using trained staff in
general practice3 20 or in the community21 and greater than
achieved in practices with the UC model where the quality was
variable and reflected the lack of GP expertise self-identified in
our qualitative data. There was a consensus that the nature of
GPs’ work was not compatible with performing spirometry to
consistently high standards, but this could be achieved with
adequate training and experience by practice nurses. A low rate
of good quality testing in practice was found previously7
although a recent study found higher rates achieved in some
practices with intensive 2 day spirometry training.22
Use of spirometry without post-bronchodilator measurement
in order to limit refusals23 may overestimate the prevalence of
airflow obstruction in each model. However, more mild
obstruction was identified by opportunistic testing compared
with testing in the UC model or as reported in an open access
spirometry service for GPs in the UK.21 Spirometry use for a
diagnosis of COPD is low with models that rely on GP initiation
or referral.24 25 Our qualitative data indicated that initiation of
testing may not occur in the absence of previously identified
disease with known underreporting by patients of symptoms.26
This study investigated the utility of different spirometry
models to increase the diagnosis of COPD in actual primary care
practice. The high level of missed opportunities for new
diagnosis in patients with airflow obstruction and mislabelling
of COPD found in practice record review are consistent with
findings in other studies in primary care.7 13 27 Methods
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suggested by GPs to improve interpretation seem feasible and
deserve further investigation.28 In addition to failure to interpret
spirometry correctly, qualitative data analysis identified other
factors contributing to non-diagnosis, including non-consulta-
tion by patients, time limitations and GPs’ preference for
reactively addressing the patient’s own agenda during a
consultation rather than being proactive. These factors have
also been found to be deterrents to GPs initiating discussions
with smokers.29
Cost effectiveness of spirometry for case finding in COPD
will vary if a symptom screening tool is used30 but depends on
subsequent reduced costs through better management and
reduced progression of the disease resulting from successful
smoking cessation.31 While we found GPs valued opportunistic
testing primarily to improve identification of smoking status
and initiate discussion on cessation, there is still no definitive
conclusion on a positive impact of spirometry on smoking
cessation.32
Consideration of the value of spirometry in primary care and
choice of the most effective model for delivery requires a full
cost–benefit analysis. Although data on costs have been
generally lacking for other models they are included here to
facilitate comparison.13 21 A cost–benefit analysis using data on
opportunistic testing in patients at risk of COPD3 carried out for
the National Institute of Clinical Excellence33 found spirometry
was relatively cost effective in case finding (assuming optimum
interpretation) compared with current practice in primary care.
Incomplete follow-up of airflow obstruction detected on
spirometry caused a large increase in cost per case in our study.
Our analysis assumes participating practices were a random
sample of those in Southern Tasmania but although they
contained a representative range, we cannot discount selection
bias and the findings may not be generalisable to all primary
care practice. UC model practices had involvement in medical
training and willingness to participate in research. They may be
more knowledgeable about guidelines and perform more
spirometry than others.34
We conclude that it is possible to increase spirometry for case
finding in primary care using a model of testing by visiting
trained nurses. However, to translate increased detection of
airflow obstruction into increased COPD diagnosis requires
measures to overcome issues identified by qualitative analysis
and, at the very least, provide GPs with assistance in
interpretation of spirometry.18
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Appendix 1
Spirometry Training Course: for general practitioners and
practice nurses
Instructors: respiratory specialist physician, pulmonary physiologist, GP.
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Course content
c Spirometry performance (40 min)
– Demonstration of simple spirometry spirogram and complex spirometry flow
volume loop
– Potential complications of spirometry
– Contraindications to spirometry:
– Requirements for achieving consistently high quality spirometry
– Test performance instructions
– Acceptance criteria (need to obtain at least 3 technically acceptable blows)
– Reproducibility criteria
– Common causes of poor quality spirometry
– How to get quality spirometry
– Trouble shooting: patient related (with examples of curves)
– Interpretation: types of ventilatory defects
– Use of predicted values
c Demonstration using EasyOne spirometer and software (20 min)
c Practice spirometry with EasyOne (30 min)
c Spirometry: application in COPD (30 min)
– Diagnosis of COPD, differentiation from asthma
– Interpretation of airflow obstruction and classification of severity
– COPDX guidelines—indications for spirometry
– Review of clinical case examples.
Appendix 2
Acceptability assessment
1. Spirometry test did not meet EasyOne spirometer criteria for an unacceptable
test:
a. back extrapolated volume greater than 150 ml or 5% whichever is greater;
b. time until peak flow greater than 120 ms;
c. expiration time less than 2 s or volume accumulation has not dropped below
100 ml per 0.5 s.
2. exhalation time (forced expiratory time) less than 6 s.
Quality grading definitions used in EasyOne spirometer:
a. at least three acceptable tests AND the difference between the best two FEV
and FVC values is equal to or less than 150 ml;
b. at least three acceptable tests AND the difference between the best two FEV
and FVC values is equal to or less than 200 ml;
c. at least two acceptable tests AND the difference between the best two FEV and
FVC values is equal to or less than 250 ml;
d. at least two acceptable trials but the results are not reproducible or only one
acceptable trial;
e. no acceptable test available.
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